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MarõÂa DiverseÂ -Pierluissi,* James Inglese,² regulation in other tissues has been well studied (Pre-
mont et al., 1995). In cardiac muscle, for example,Robert H. Stoffel,³ Robert J. Lefkowitz,³
b1-adrenergic receptors desensitize as a result of theirand Kathleen Dunlap*
phosphorylation by protein kinase A (heterologous de-*Departments of Physiology and Neuroscience
sensitization) or G protein±coupled receptor kinasesTufts University School of Medicine
(GRKs) (homologous desensitization) (Freedman et al.,Boston, Massachusetts 02111
1995). The former can proceed in the absence of ago-²Pharmacopeia Incorporated
nist±receptor binding, but homologous desensitization201 College Road East
occurs only in the presence of high agonist concentra-Princeton, New Jersey 08540
tions (Hausdorf et al., 1990). In both cases, phosphoryla-³Howard Hughes Medical Institute
tion reduces receptor affinity and is responsible forDepartments of Medicine and Biochemistry
reducing receptor±G protein coupling and agonist-Duke University School of Medicine
mediated signaling.Durham, North Carolina 27710
It is likely that similar mechanisms control the efficacy
of metabotropic synaptic transmission as well. Homolo-
gous desensitization is of particular interest, since trans-
mitters can approach millimolar concentrations at syn-Summary
aptic sites during the peak of transmission (Clements
et al., 1992) and since GRKs are expressed widely andG protein±coupled receptors are essential signaling
abundantly in nervous tissue (Arriza et al., 1992). Asmolecules at sites of synaptic transmission. Here, we
neuronal metabotropic receptor desensitization hasexplore the mechanisms responsible for the use-
been little explored, we undertook experiments to inves-dependent termination of metabotropic receptor sig-
tigate the role of GRKs in homologous desensitizationnaling in embryonic sensory neurons. We report that
of a2-adrenergic receptors in isolated embryonic chickthe inhibition of voltage-dependent Ca21 channels me-
sensory neurons. These G protein±coupled receptorsdiated by a2-adrenergic receptors desensitizes slowly
inhibit voltage-dependent, somatic Ca21 currents in sen-with prolonged exposure to the transmitter and that
sory neurons by two distinct biochemical pathways,the desensitization is mediated by a G protein±coupled
each producing a unique effect on N current (DiverseÂ -receptor kinase (GRK). Intracellular introduction of re-
Pierluissi et al., 1995). Norepinephrine (NE), via Go, slowscombinant, purified kinases or synthetic blocking pep-
the kinetics of Ca21 current activation, an effect thattides into individualneurons demonstrates the specific
subsides with time at positive potentials; a second, sus-involvement of a GRK3-like protein. These results sug-
tained reduction in Ca21 current, via Gi, is also observed.gest that GRK-mediated termination of receptor±G
The latter effect of NE requires the activation of protein
protein coupling is likely to regulate synaptic strength
kinase C, while kinetic slowing does not (DiverseÂ -Pier-
and, as such, may provide one effective mechanism luissi and Dunlap, 1993). By reducing Ca21 entry, the
for depression of synaptic transmission. a2-adrenergic receptors are thought to inhibit transmit-
ter release from sensory nerve terminals and attenuate
synaptic transmission between the sensory cells andIntroduction
their targets in the spinal cord (Headley et al., 1978).
Such G protein±coupled transmitter responses sub-Agonist-mediated desensitization of postsynaptic, iono-
side (or desensitize) relatively slowly in the face of per-tropic receptors responsible for fast synaptic transmis-
sistent elevation in transmitter concentration (Klein et
sion, such as GABAergic and glutamatergic receptors,
al., 1989). Here, we describe the desensitization time
represents an important activity-dependent mechanism
course for the a2-adrenergic receptor±mediated inhibi-for controlling synaptic strength in the nervous system tion of Ca21 current in isolated, intact chick sensory
(Huganir and Greengard, 1990). High concentrations of neurons. We demonstrate that its rate is controlled se-
transmitter, such as those maximally achieved in the lectively by an endogenous GRK similar to the b-adren-
synaptic cleft during transmission, promote receptor de- ergic receptor kinase type 2 (also called GRK3). The
sensitization, an attenuation of receptor responsiveness clear GRK specificity observed in our experiments was
to agonist. At certain synapses, desensitization of iono- surprising, in light of previous results from in vitro bio-
tropic receptors is rapid and plays a role in terminating chemical assays that demonstrate little specificity
the synaptic response (Trussell et al., 1993); at others, among particular GRKs (Inglese et al., 1993; Haga et
desensitization is slower and modulates the amplitude al., 1994). These results underscore the power of using
of transmission only during trains of stimuli (Huganir and functional assays of single cells to sort out the physio-
Greengard, 1990). logical roles of the GRKs.
In addition to ionotropic receptor±mediated, fast syn-
aptic transmission, signaling in the nervous system also Results
relies heavily on metabotropic, G protein±coupled re-
ceptors for more sustained synaptic action (Klein et al., Desensitization of NE-Induced Inhibition
1989). The mechanisms responsible for controlling the of Ca21 Current
response time course of such receptors at sites of syn- Embryonic chick dorsal root ganglion neurons were volt-
age clamped using tight seal, whole-cell recordingaptic transmission arepoorly understood; however, their
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Figure 1. NE-Induced Desensitization of Ca21 Current in Sensory Neurons
Peak (A and B) or normalized (C) Ca21 currents are plotted as a function of time before and during (horizontal bar) application of NE. In (A),
a brief application period of 40 s is followed by washout of transmitter and full recovery of the current (open circles, n 5 3); closed circles
represent the average time course for Ca21 current rundown in 3 cells measured from the same culture dish. (B) shows plotted data from a
single cell during prolonged application of 100 mM NE. (C) shows plotted averaged, Ca21 currents normalized to maximum control current
(n 5 3) before and during application of 100 mM (open circles) or 10 mM (D) NE. Standard errors of the mean fall within the symbol boundaries
for most data points (range 6 0.03±0.07).
methods, and their Ca21 currents were evoked by step produce maximal desensitization, consistent with previ-
ous findings that the rate-limiting step for Ca21 channeldepolarizations and measured over time. Under our re-
cording conditions, applying 100 ms test pulses to 0 mV inhibition lies beyond the receptor and G protein (Di-
verseÂ -Pierluissi and Dunlap, 1995).produced Ca21 currents that averaged 1.2 6 0.3 nA at
their peak (n 5 40). These currents are blocked >90% by
1 mM v-conotoxin GVIA, characterizing them as N-type Two Modulatory Components Desensitize
(data not shown, see Cox and Dunlap, 1992). Peak N at Different Rates
current declined slowly with time, at a rate of z1%/min. Our previous work has demonstrated that NE inhibits
As reported by others (Jones and Marks, 1989; Elmslie Ca21 current by two separate biochemical pathways
et al., 1993), such rundown was irreversible and, be- (Luebke and Dunlap, 1994; DiverseÂ -Pierluissi et al.,
cause of its slow rate, could be easily separated from 1995), a Go-mediated pathway producing voltage-
the more rapid onset and recovery of agonist-induced dependent slowing of the current activation kinetics
inhibition (Figure 1A). All experimental results reported (termed kinetic slowing or KS) and a Gi-mediated path-
below have been corrected for the average rate of run- way producing voltage-independent inhibition without
down measured from control cells studied in parallel. changing the activation kinetics (termed steady-state
Bath application of 100 mM NE inhibited N current by inhibition or SSI). These two components were sepa-
an average 50% 6 7% (n 5 10) within 10 s, and upon rated and their rates of desensitization were studied
termination of transmitter application, responses recov- independentlyusing themethods outlined in Experimen-
ered completely within 30 s (Figure 1A, inset). With con- tal Procedures. Half-maximal desensitization of KS oc-
tinued superfusion of NE, the inhibition recovered slowly curred in 60 s and was complete by 100 s. By contrast,
(Figure 1B); this recovery process will be called desensi- desensitization of SSI proceeded more slowly (half-max-
tization. Its rate was estimated as the time required imal effects were observed at 100 s) and was only 80%
to achieve half-maximal recovery, 100 s under control complete, even following application of 100 mM trans-
conditions (n 5 3). On average, peak current (corrected mitter (Figure 2).
for rundown) returned to within 80% of control.
Effects of Purified GRKs
To evaluate whether GRKs play a role in a2-adrenergicConcentration Dependence
of the Desensitization receptor desensitization in sensory neurons, we injected
individual neurons with recombinant GRKs (expressedThe desensitization rate was an inverse function of
transmitter concentration (Figure 1C), as expected for in and purified from baculovirus-infected Sf9 cells). The
GRKs were added to the pipette at a concentration ofhomologous receptor desensitization. Application of 10
mM NEinhibited peak Ca21 currentby 45% 6 6%, almost 10 ng/ml and were pressure-injected into the cells in
the presence of fluorescein±dextran. Following a 60 minas effective as 100 mM NE (Canfield and Dunlap, 1984).
Desensitization of the response was greatly slowed, postinjection incubation period, cells were identified by
their fluorescence, and Ca21 currents were studied underhowever, at the lower concentration of transmitter (Fig-
ure 1C), with little or no desensitization detected in 10 whole-cell recording. Currents were evoked every 20 s
(or every 5 s where noted) throughout the experiment,min. Lower concentrations of NE (1 mM) were also
tested; inhibition of 15% 6 5% showed no desensitiza- and responses to 100 mM NE were compared with those
evoked in control, uninjected cells. None of the GRKstion over a 12 min monitoring period (data not shown).
Thus, concentrations of NE that saturate the pathway tested had any effect on basal Ca21 current amplitude
(1.2 6 0.3 nA in control and 1.2 6 0.4 nA in GRK-injectedfor onset of Ca21 current inhibition are insufficient to
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Figure 2. Two Modulatory Components Desensitize at Different
Rates
Kinetic slowing and steady-state inhibition were separated ac-
cording to the methods described in Experimental Procedures. The
average percentage inhibition (n 5 3) is plotted as a function of
time for each component. Time zero marks the beginning of NE
application; the plotted data begin at the time at which maximal
inhibition was reached. Standard errors of the mean fall within the
symbol boundaries for most data points (range 6 0.6±4%). Inset;
Figure 4. Activity of GRK2 and GRK3 on b2AR and Western Blotsuperimposed currents demonstrating the isochronal measurement
Analysis of Protein from Dorsal Root Gangliaof kinetic slowing (ks) and steady-state inhibition (ssi).
(A) Kinase activities of GRK2 and GRK3 on b2AR were assessed in
the absence and presence of bg (28 mg/ml), as marked. The graph
cells, n 5 30). Furthermore, the maximal inhibition pro- is representative of two individual experiments, each performed in
duced by NE was unaffected by the presence of the triplicate. Data are plotted as the mean 6 standard deviation. (B)
Western blot of recombinant GRK2 (10 ng, rGRK2), GRK3 (10 ng,GRKs.
rGRK3), and dorsal root ganglia (100 mg, DRG) probed with antise-GRK3, however, enhanced the rate of desensitization
rum that recognizes both GRK2 and GRK3. Data are representativeof the NE effect (Figure 3). Both modulatory components
of five separate experiments on two separate preparations of dorsal
were enhanced by GRK3. KS desensitized by half in 30 root ganglia.
s in GRK3-injected cells, approximately 2-fold faster
than that measured in control cells. Desensitization of
SSI was half complete in 50 s (also 2-fold faster than enzymes, we performed in vitro phosphorylation assays
in parallel with the electrophysiological experiments.control) and resulted in a full recovery of the control
amplitude. This enhancing effect of GRK3 was specific. Results from these assays (Figure 4) show that the prep-
arations of GRK2 and GRK3 used in the electrophysio-No alterations in the rate of desensitization were ob-
served in cells injected with equivalent concentrations logical experiments were equally effective in phosphory-
lating the b2-adrenergic receptor in vitro, underscoringof GRK1 (rhodopsin kinase), GRK2 (bARK1), or GRK5.
As with GRK3, these other GRKs were without effect the selectivity of GRK3 action in the sensory neurons.
on control Ca21 current amplitude or maximal inhibition
produced by NE (data not shown). Evidence for Endogenous GRKs
GRK-Blocking PeptidesSince GRK2 and GRK3 are 90% homologous, it was
surprising that only GRK3 was effective in altering the To test whether desensitization under normal physiolog-
ical conditions is mediated by a GRK3-like moleculerate of desensitization in sensory neurons. To test for
possible differences in the affinities or rates of GRK in sensory neurons, we employed synthetic peptides
known to interfere with GRK translocation and activationaction, we increased the concentration of injected GRK2
to 250 ng/ml; even this higher concentration was without (Koch et al., 1993). These 20 amino acid peptides have
sequences identical to GRK carboxy-terminal domainseffect on the rate of desensitization (data not shown). To
control for possible differences in activity of the injected thought to be involved in binding Gbg (Koch et al., 1993)
Figure 3. GRK3 Enhances Desensitization of
the NE Response
The fraction of NE-induced kinetic slowing
(A) and steady-state inhibition (B) are plotted
as a function of time for control (circles),
GRK3-injected (triangles), and GRK2-injected
(squares) cells. Time zero marks the time at
which maximal inhibition was achieved. Data
points represent the average of three cells.
Standard errors of the mean fall within the
symbol boundaries for most data points
(range 6 0±0.05).
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Immunoassays for Endogenous GRKs
In parallel biochemical experiments, anti-GRK antisera
were used to assess which types of GRK are expressed
in embryonic chick sensory neurons. An immunoblot
probed with antiserum raised against thecarboxyl termi-
nus of GRK3, which also recognizes GRK2, revealed a
protein in sensory neurons that migrates on acrylamide
gel with the same mobility as that of recombinant GRK3
(Figure 4B). No other GRKs were detected when similar
immunoblots were probed with GRK2 and GRK5 anti-
sera (data not shown).
Figure 5. Peptide G Retards Desensitization of the NE Response Discussion
The fraction of maximal inhibition is plotted as a function of time
for NE-induced kinetic slowing (closed circles) and steady-state
Our results demonstrate that a GRK similar or identicalinhibition (open circles). Transmitter (100 mM) was applied for the
to GRK3 plays a pivotal role in terminating the inhibitionperiod marked by the horizontal bar (NE) and then washed out of
the bath during the period marked by the dashed line (wash). Data of Ca21 channels mediated by a2-adrenergic receptors
points represent the average of three cells. Standard errors of the in embryonic chick sensory neurons. The specific
mean fall within the symbol boundaries for most data points (range involvement of a GRK3-like protein is supported by our
6 0±0.08). findings that recombinant GRK3 (but not GRK1, GRK2,
or GRK5) was effective in promoting desensitization that
a synthetic peptide corresponding to the Gbg-bindingand translocation to the membrane site from where the
kinases phosphorylate receptors (Premont et al., 1995). domain of GRK3 (peptide G) blocked desensitization but
the homologous peptide from GRK2 did not; and that aThe peptides were introduced into sensory neurons by
adding them at 100 mM to the patch pipette solution GRK3-like protein was detected in immunoblot assays
of protein from cultured sensory neurons.and allowing them to diffuse into the cell cytoplasm.
After 10±12 min diffusion time, the cells were tested with That desensitization of NE-mediated Ca21 channel in-
hibition in sensory neurons involves a bARK-like kinase100 mM NE and responses compared with those from
control cells exposed for an equal amount of time to is consistent with reports that bARK1 and bARK2 (GRK2
and GRK3, respectively) are expressed widely in thenormal internal solution.
Peptide G, representing residues Trp-643 to Ser-670 nervous system (Arriza et al., 1992) and that a2-adrener-
gic receptors are known substrates for bARK (Benovicof GRK3 (which contains the Gbg-binding site; Touhara
et al., 1995), greatly slowed the rate of desensitization for et al., 1987). The inefficacy of GRK1 (rhodopsin kinase)
and GRK5 in sensory neurons is further consistent withboth KS and SSI, without altering peak currentmeasured
prior to NE application or its maximal inhibition by the the reduced ability of these GRKs to phosphorylate
a2-adrenergic receptors in vitro (Benovic et al., 1987;transmitter. During a 6 min application of transmitter,
the SSI component did not reverse at all in peptide Pei et al., 1994) as well as with the reported fundamental
mechanistic differences in activation of GRK1 andG±treated cells, while the KS component showed a
much reduced rate of recovery, to within 65% of control GRK5, as compared with those for GRK3 (Premont et
al., 1995).Ca21 current (Figure 5). This action of the GRK3 peptide
G was specific: the corresponding Gbg-binding peptide The absence of GRK2-mediated desensitization of the
NE response in sensory neurons was surprising in lightfrom GRK2 (at 100 mM) failed to alter the time course
of desensitization or the magnitude of the NE-mediated of the structural and functional similarities reported for
GRK2 and GRK3. Their primary structures are greaterSSI when applied to sensory neurons (n 5 6); peptide
A (100 mM), representing residues Ala-531 to Trp-553 than 90% identical (Benovic et al., 1991), their activation
requires a Gbg-mediated translocation to the membraneof GRK3 (a sequence that occurs in a region of GRK3
outside of the putative Gbg-binding domain) was also (Pitcher et al., 1992), and their efficacies for phosphory-
lating a number of receptor types in vitro are similarwithout effect (n 5 5). These findings strongly suggest
that Gbg-binding sites of GRK2 and GRK3 allow the (Inglese et al., 1993; Pei et al., 1994). The fact that the
specific G peptide from GRK3 blocks a2-adrenergic re-kinases to interact selectively with different Gbgs.
In addition to its effect on the extent and rate of desen- ceptor desensitization in sensory neurons (while that
from GRK2 does not) suggests a significant degree ofsitization, peptide G (from GRK3) also reduced the mag-
nitude of NE-mediated SSI. The mean inhibition was selectivity in the interactions between the GRKs and the
Gbgs that has not, as yet, been demonstrated in in vitro45% 1 6% (n 5 10) in control cells and 25% 6 5%
(n 5 12) in peptide G±treated cells. The magnitude of biochemical assays (Pitcher et al., 1992; Koch et al.,
1993; Premont et al., 1995). It remains to be determinedthe kinetic slowing component was unaltered, and pep-
tide A was without effect. The blocking action of peptide whether the a2-adrenergic receptor±coupled signaling
pathways in chick sensory neurons are unique in thisG was predictable, as Gbg is a known intermediate in
the signaling pathway producing SSI (DiverseÂ -Pierluissi ability to discriminate between GRK2 and GRK3. Per-
haps more likely, the GRKs may show reduced specific-et al., 1995). Thus, peptide G simultaneously reduces
NE-mediated SSI and GRK-mediated desensitization ity for certain receptors when the molecules are assayed
in vitro or overexpressed in foreign environments. Inthrough its competition for Gbg binding.
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support of this idea is a previous report that GRK3 is manner. GRK-mediated termination mechanisms at
sites of synaptic contact may be particularly importantmore effective than GRK2 at mediating desensitization
of odorant-induced signaling in excised olfactory cilia for regulating transmission via metabotropic receptors.
It will be interesting to test whether GRK-induced desen-(Schleicher et al., 1993). Future studies of GRK-receptor
specificity will be greatly aided by single cell assays sitization plays a role in the rapid termination of transmit-
ter-induced synaptic responses, longer term synapticsuch as that reported here. KS and SSI desensitized at
significantly different rates in ourstudies. The underlying depression, or both.
Although these ideas have not been tested in thebiochemical explanation for this is unknown, and explor-
ing it is complicated by several properties inherent in nervous system, GRK3 has been reported to terminate
rapidly odorant-induced responses in excised cilia fromthe signaling pathways. Gibg appears to be activating
two effectors with opposing actions on Ca21 current: olfactory neurons (Schleicher et al., 1993) and is consid-
ered essential to odorant discrimination in olfactory epi-phospholipase C, which produces SSI via protein kinase
C±mediated phosphorylation (DiverseÂ -Pierluissi et al., thelium (Boekhoff and Breer, 1992; Schleicher et al.,
1993). In addition, slower desensitization processes are1995), and GRK3, which enhances the current via recep-
tor±G protein uncoupling (as shown here). By contrast, well known to regulate cardiac sensitivity to circulating
hormone levels (Homcy et al., 1991). For example,during KS, Goa appears to inhibit the current (DiverseÂ -
Pierluissi et al., 1995), while Gob activates GRK. The b-adrenergic receptor function is impaired during heart
failure (Bristow and Feldman, 1992). Human samplesselectivity of the Goa for KS is suggested indirectly from
experiments showing that purified Gbg produces N cur- from failing ventricles showa loss of b-adrenergic recep-
tor±G protein coupling and increased levels of bARK1rent inhibition without altering the activation kinetics.
Given that different subunits mediate the two modula- (Ungerer et al., 1994). Furthermore, transgenic mice that
overexpress bARK1 demonstrate reduced cardiac con-tory pathways and that the subunits can interact with
multiple effectors, differences in desensitization rates tractility in response to isoproterenol, while mice overex-
pressing a bARK inhibitor showed increased contractil-might be predicted even if a2-adrenergic receptor cou-
pling to Gi and Go were equally effective. ity (Koch et al., 1995).
Voltage-activated Ca21 channels, by virtue of theirTo this complexity must also be added uncertainties
about the number of a2-adrenergic receptor types in- direct involvement in transmitter release, provide an ef-
fective target for use-dependent signaling pathways involved in KS and SSI. This issue is an important one,
as others report that a2-adrenergic receptors undergo the nervous system. The complex machinery controlling
N channel inhibition in sensory neurons provides greatsubtype-specific, short-term desensitization (Eason and
Liggett, 1992; Kurose and Lefkowitz, 1994). Thus, the flexibility in both onset and desensitization of the ago-
nist-induced response. Such complexity likely underliespossible involvement of multiple receptor types in sen-
sory neurons provides a simple explanation for why KS the multifaceted responses of neural networks to
changes in physiological input as well.and SSI desensitize at different rates. It is presently
unknown whether each modulatory pathway in sensory
neurons is activated by a separate receptor or whether Experimental Procedures
a single receptor type couples to both Gi and Go. Identi-
Cell Culturefying the rate-limiting steps in desensitization, therefore,
Embryonic chicken sensory neurons were grown in culture ac-awaits studies using recombinant G protein subunits
cording to methods described in detail elsewhere (Canfield and
and blocking peptides. Dunlap, 1984). Dorsal root ganglia were dissected from 11 to 12
Given the mechanistic differences between KS and day old embryos, incubated for 30 min in saline containing nominal
SSI, it is noteworthy that desensitization of the two were Ca21 and Mg21, and 0.05% collagenase (type A, Boehringer-Mann-
heim). Ganglia were dissociated mechanically into single cells bysimilarly enhanced by GRK3 and retarded by peptide
trituration in culture medium containing Dulbecco's modifiedEagle'sG. Receptor phosphorylation induced by GRK3 involves
medium supplemented with 10% horse serum, 5% chicken embryoa translocation of thekinase to the membrane, a process
extract, penicillin, streptomycin, glutamine, and nerve growth factor.
that is facilitated by its binding to the Gbg subunit of the Cells were plated at a density of z50,000 cells/collagen-coated 35
activated G protein (Pitcher et al., 1992). The common mm tissue culture dish and studied between 1 and 3 days in vitro.
action of GRK3 against KS and SSI, therefore, implies
that the Gbgs from Gi and Go are similar. Biochemical Electrophysiological Recording
assays of protein in vitro have yet to demonstrate selec- Standard tight seal, whole-cell recording methods (Hamill et al.,
1981) were employed. Cells were incubated in an external solutiontive interactions between the GRKs and Gbg purified
containing 133 mM NaCl,1 mM CaCl2, O.8 mM MgCl2, 25 mM HEPES,from bovine brain (Pitcher et al., 1992; Koch et al., 1993;
12.5 mM NaOH, 5mM glucose,10 mM tetraethylammonium chloride,Premont et al., 1995; cf. Muller et al., 1993). However,
0.3 mM tetrodotoxin (pH 7.4). Experiments were performed on the
as bovine brain Gbg is a mixture of subunit types, the stage of an inverted microscope. Recording pipettes were fabri-
specificity of interaction might bemore effectively evalu- cated from microhematocrit tubing (Fisher) and filled with an internal
ated using recombinant Gbg dimers, for which subunit recording solution containing 150 mM CsCl, 5 BAPTA, 5 MgATP,
10 HEPES (pH 7.2). All salts were obtained from Fluka. Initial pipettecomposition is known.
resistances were 0.8±1.2 MV. Signals from a List EPC7 amplifierThe efficacy and specificity of the GRK-mediated de-
were filtered at 3 kHz, digitized at 10 kHz using an ITC16 A/D inter-sensitization demonstrated here suggest important
face (Instrutech Corp, Great Neck, NY), and stored for later analysis
physiological implications for signaling in the nervous on a Macintosh computer with software by HEKA Elektronik (Federal
system. Because such alterations in receptor±G protein Republic of Germany).
coupling require agonist binding, they are ideally suited The two components of norepinephrine-induced inhibition were
separated using methods described previously (DiverseÂ -Pierluissi etto regulate cellular responsiveness in a use-dependent
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al., 1995). The control current was first normalized to the modulated dithiothreitol containing 100 mM ATP, and 100 mM isoproterenol in
a total volume of 25 ml.current at the end of a 100 ms pulse (after kinetic slowing had largely
subsided). The KS component was then taken as the difference
between the normalized current and the modulated current. The SSI
component was taken as the difference between the normalized Acknowledgments
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